Results
MSSA bacteremia
MAY
Between 31 May 2019 and 24 February 2022, we assessed 925 patients with MSSA bacteremia for eligibility. After excluding 710 patients who were considered ineligible, we enrolled 215 patients, who were randomly assigned to receive cloxacillin plus fosfomycin (